Recent evidence in T cell-inflamed tumors highlights the key role of CD103+ DCs in the baseline CD8+ CTL-mediated immune response against tumor antigens, and their presence in the TME of human tumors correlates with the secretion of CXCL9/10 [56]. Here, CXCL9 is linked to neoplasm.